This article was originally published in The Gray Sheet
Names Ray Lavoie to the new position of vice president, U.S. cardiac surgery sales. Lavoie has worked for the Minneapolis-based company for 23 years, serving most recently as regional vice president for sales of Medtronic's cardiovascular products in the Midwest
You may also be interested in...
Lead immuno-oncology asset NC318 targeting Siglec-15 showed encouraging early activity in patients refractory to PD-1/L1 inhibitors, but now Phase II plans are scuttled in lung and ovarian cancers.
Pataday Once Daily Relief Extra Strength is the same formulation as Novartis' Rx Pazeo. It will be the first OTC eye drop indicated for allergy itch with 24-hour efficacy, available online in September and through retailers in early 2021.
Bristol makes its own deal with Celgene ally Dragonfly, while Gilead ends virology partnerships with Durect and Precision BioSciences.